BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15936816)

  • 1. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
    Brakensiek K; Länger F; Kreipe H; Lehmann U
    Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of mice without Cip/Kip CDK inhibitors.
    Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
    Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of cell cycle control genes in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of cyclin-dependent kinase inhibitors in leukemia].
    Polák J; Peková S; Schwarz J; Kozák T; Haskovec C
    Cas Lek Cesk; 2003 Jan; 142(1):25-8. PubMed ID: 12693294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas.
    Go JH
    Mod Pathol; 2003 Aug; 16(8):752-5. PubMed ID: 12920218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients.
    Chim CS; Fung TK; Wong KF; Lau JS; Law M; Liang R
    J Clin Pathol; 2006 Sep; 59(9):921-6. PubMed ID: 16565223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and mutational analysis of Cip/Kip family in early glottic cancer.
    Kim DK; Lee JH; Lee OJ; Park CH
    J Laryngol Otol; 2015 Feb; 129(2):168-73. PubMed ID: 25695279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation in promoter regions of cyclin-dependent kinase inhibitor genes in adenoid cystic carcinoma of the salivary gland.
    Daa T; Kashima K; Kondo Y; Yada N; Suzuki M; Yokoyama S
    APMIS; 2008 Jan; 116(1):21-6. PubMed ID: 18254776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.
    Shin JY; Kim HS; Park J; Park JB; Lee JY
    Cancer Res; 2000 Jan; 60(2):262-5. PubMed ID: 10667572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
    Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P15(INK4B) gene methylation in malignant hematopoietic diseases].
    Wu Q; Guo X; Fan H; Zhou T; Tan G; Guo Q; Chen P; Zhang X; Luo G; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):644-6. PubMed ID: 11877040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of cell cycle regulatory genes during 3-methylcholanthrene and diethylnitrosamine-induced multistep rat lung cancer.
    Liu WB; Liu JY; Ao L; Zhou ZY; Zhou YH; Cui ZH; Cao J
    Mol Carcinog; 2010 Jun; 49(6):556-65. PubMed ID: 20512841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p57KIP2: "Kip"ing the cell under control.
    Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
    Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of the CIP/KIP family of CDK inhibitor proteins in primary intestinal large B-cell lymphomas: correlation with clinical outcomes.
    Go JH
    Pathol Res Pract; 2002; 198(11):741-6. PubMed ID: 12530577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
    Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
    Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.